Cited by 479Inflammatory mediators and NSAID effectsNF-κB Signaling PathwaysEicosanoids and Hypertension Pharmacology

Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial Cells

Open access
Inoue, Hiroyasu, Yokoyama, Chieko, Hara, Shuntaro, Tone, Yoshinori, Tanabe, Tadashi·1995·Journal of Biological Chemistry

Abstract

There exist two distinct isozymes of prostaglandin-endoperoxide synthase (PES). PES-2 mRNA is synergistically induced by lipopolysaccharide (LPS) and 12-O-tetradecanoylphorbol-13-acetate (TPA) in bovine arterial endothelial cells. On the other hand, PES-1 mRNA is constitutively expressed under these conditions. Therefore, the promoter activities of the human genes for PES-1 and -2 in bovine arterial endothelial cells were examined. The 5'-flanking region of the human PES-2 gene (nucleotides -327 to +59) showed promoter activity inducible by LPS and TPA using transient transfection analysis, whereas that of the PES-1 gene (nucleotides -1010 to +69) showed constitutive promoter activity. Destruction of both consensus sequences for the nuclear factor responsible for the interleukin-6 expression (NF-IL6) site (nucleotides -132 to -124) and the cyclic AMP response element (CRE) (nucleotides -59 to -53) of the human PES-2 gene markedly reduced the promoter activity (25%) of the PES-2 gene after combined treatment with LPS and TPA, although single destruction of the NF-IL6 site or the CRE slightly reduced the promoter activity (60 or 90%, respectively). Moreover, cotransfection experiments showed that a trans-acting factor, CCAAT enhancer binding protein delta (C/EBP delta), which binds to both the NF-IL6 site and the CRE, increased the promoter activity of the PES-2 gene mainly through the CRE. C/EBP delta mRNA was rapidly induced by LPS. Collectively, these results suggest that transcription of the PES-2 gene in vascular endothelial cells is regulated through combination of the NF-IL6 site and the CRE and that C/EBP delta functions as one of the trans-acting factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.270.42.24965

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibition of COX-2 activity or expression by some anti-inflammatory agents is due to interference with signalling mechanisms regulating the COX-2 gene; NF-κB, C/EBP, AP-1, and CREB have been identified as regulators of COX-2 transcription.

    “The inhibition of activity or expression of COX-2 by some anti-inflammatory is due to the interference with the signalling mechanisms that regulate the COX-2 gene. In this gene, four transcription factors including NF-κB, CCAAT/enhancer-binding protein (C/EBP), activator protein 1 (AP-1) and CRE-binding protein (CREB) have been identified as regulators of COX-2 transcription [22,126].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. O'Banion, M. K., Winn, V. D., and Young, D. A. (1992) Proc. Natl. Acad. Sci.
  2. Hla, T., and Neilson, K. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7384 -7388
  3. Kinoshita, S., Akira, S., and Kishimoto, T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 1473-1476
  4. LeClair, K. P., Blanar, M. A., and Sharp, P. A. (1992) Proc. Natl. Acad. Sci.
  5. Montminy, M. R., Sevarino, K. A., Wagner, J. A., Mandel, G., and Goodman, R. H. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 6682-6686
  6. Silver, B. J., Bokar, J. A., Virgin, J. B., Vallen, E. A., Milsted, A., and Nilson, J. H. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2198 -2202

Cited by

Sorted by citations

Authors
Inoue, H., Yokoyama, C., Hara, S., Tone, Y., & Tanabe, T.
Affiliations
National Cerebral and Cardiovascular Center (JP)
Corresponding author
Tanabe, Tadashi
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1995-10
Volume
270
Issue
42
Pages
24965-24971
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2082728629
Cited by
479
References
37
Citations by year
2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 11 · 2012: 11
FWCI
18.48
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • McKnight Foundation
  • Japan Science and Technology Agency
Topics
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
cyclooxygenase-2, transcriptional regulation, lipopolysaccharide, phorbol ester, phorbol myristate acetate, vascular endothelial cells, promoter activity, cyclic AMP response element, C/EBPδ, trans-acting factors, gene induction
MeSH terms
Cyclic AMP, Animals, Base Sequence, Cattle, DNA-Binding Proteins, Endothelium, Vascular, Gene Expression Regulation, Humans, Lipopolysaccharides, Molecular Sequence Data, Promoter Regions, Genetic, Prostaglandin-Endoperoxide Synthases, Tetradecanoylphorbol Acetate, Transcription, Genetic, Interleukin-6, Cyclic AMP Response Element-Binding Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review